Mina Nikanjam

12PUBLICATIONS
21CO-AUTHORS
International arbitrationPredictive and prognostic markersMolecular targetsTumour immunologyImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jun 30, 2026
Claudin 18.2 Targeting: A Pan-Cancer Perspective.

|May 25, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.

|May 05, 2026
GITR and GITR-L RNA Expression Levels Correlate with Better Survival and Response to Immunotherapy.

|Jan 08, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug Combinations.

Jason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita

|Dec 31, 2025
Inducible T-Cell Co-Stimulator (ICOS) and ICOS Ligand: Dealing With a Two-Faced Cancer Immunoregulatory System.

Mina Nikanjam, Shumei Kato, Daisuke Nishizaki

|Apr 29, 2025
ICOS and ICOS ligand: expression patterns and outcomes in oncology patients.

Mina Nikanjam, Shumei Kato, Daisuke Nishizaki

Pageof 2

Frequent Collaborators

6 joint publications

Razelle Kurzrock

4 joint publications

Jason K Sicklick

3 joint publications

Daisuke Nishizaki

3 joint publications

Hirotaka Miyashita